IN8BIO, INC. Variable Lease, Cost
IN8BIO, INC. (INAB) reported Variable Lease, Cost of $27.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-08-06
- IN8BIO, INC. variable lease, cost for the quarter ending 2026-06-30 was $27.00K, a 15.63% decline year-over-year.
- IN8BIO, INC. variable lease, cost for the quarter ending 2026-03-31 was $28.00K, a 6.67% decline year-over-year.
- IN8BIO, INC. variable lease, cost for the quarter ending 2025-12-31 was $128.00K, a 255.56% increase year-over-year.
- IN8BIO, INC. variable lease, cost for the quarter ending 2025-09-30 was $60.00K, a 57.89% increase year-over-year.
- IN8BIO, INC. variable lease, cost for fiscal 2025 was $220.00K, a 64.18% increase from fiscal 2024.
- IN8BIO, INC. variable lease, cost for fiscal 2024 was $134.00K, a 15.52% increase from fiscal 2023.
- IN8BIO, INC. variable lease, cost for fiscal 2023 was $116.00K.
- IN8BIO, INC. variable lease, cost for fiscal 2022 was $0.00.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $27.00K 10-Q · filed 2026-08-06 | $55.00K 10-Q · filed 2026-08-06 | $183.00K derived: sum of 3 quarters · filed 2026-08-06 | $243.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $28.00K 10-Q · filed 2026-05-07 | $156.00K derived: sum of 2 quarters · filed 2026-05-07 | $216.00K derived: sum of 3 quarters · filed 2026-05-07 | $248.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $128.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $188.00K derived: sum of 2 quarters · filed 2026-03-12 | $220.00K derived: sum of 3 quarters · filed 2026-08-06 | $220.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $60.00K 10-Q · filed 2025-11-06 | $92.00K derived: sum of 2 quarters · filed 2026-08-06 | $92.00K 10-Q · filed 2025-11-06 | $158.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $32.00K 10-Q · filed 2026-08-06 | $62.00K 10-Q · filed 2026-08-06 | $98.00K derived: sum of 3 quarters · filed 2026-08-06 | $136.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $30.00K 10-Q · filed 2026-05-07 | $66.00K derived: sum of 2 quarters · filed 2026-05-07 | $104.00K derived: sum of 3 quarters · filed 2026-05-07 | $140.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $74.00K derived: sum of 2 quarters · filed 2026-03-12 | $110.00K derived: sum of 3 quarters · filed 2026-03-12 | $134.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $38.00K 10-Q · filed 2025-11-06 | $74.00K derived: sum of 2 quarters · filed 2025-11-06 | $98.00K 10-Q · filed 2025-11-06 | $214.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $36.00K 10-Q · filed 2025-08-07 | $60.00K 10-Q · filed 2025-08-07 | $176.00K derived: sum of 3 quarters · filed 2025-08-07 | $176.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $24.00K 10-Q · filed 2025-05-07 | $140.00K derived: sum of 2 quarters · filed 2025-05-07 | $140.00K derived: sum of 3 quarters · filed 2025-05-07 | $140.00K derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | $116.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $116.00K derived: sum of 2 quarters · filed 2025-03-13 | $116.00K derived: sum of 3 quarters · filed 2025-03-13 | $116.00K 10-K · filed 2025-03-13 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | $0.00 10-K · filed 2024-03-14 | |||
| 2021-06-30 | $0.00 10-Q · filed 2021-09-10 | $0.00 10-Q · filed 2021-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B |